| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. | Chief Operating Officer | Restricted Stock Units | 77.5K | $793K | $10.24 | Jan 1, 2024 | Direct |
| Xilio Therapeutics, Inc. | Chief Operating Officer | Stock Option (right to buy) | 52K | Aug 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2024 | 1 | $0 | 4 | Aug 6, 2024 | Chief Operating Officer |
| XLO | Xilio Therapeutics, Inc. | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Aug 16, 2023 | 1 | $0 | 4 | Aug 18, 2023 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2023 | 1 | $0 | 4 | Aug 7, 2023 | Chief Operating Officer |
| XLO | Xilio Therapeutics, Inc. | Aug 3, 2023 | 0 | $0 | 3 | Aug 7, 2023 | Chief Operating Officer |